BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 32798155)

  • 1. Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis.
    Yaeger R; Paroder V; Bates DDB; Capanu M; Chou J; Tang L; Chatila W; Schultz N; Hersch J; Kelsen D
    Clin Colorectal Cancer; 2020 Dec; 19(4):e151-e156. PubMed ID: 32798155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological differentiation between sporadic and colitis-associated intestinal cancer in a nationwide study: A propensity-score-matched analysis.
    Uchino M; Ikeuchi H; Noguchi T; Okabayashi K; Futami K; Tanaka S; Ohge H; Watanabe K; Itabashi M; Okamoto K; Okita Y; Mizushima T; Mizuuchi Y; Yamada K; Shimada Y; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Hanai T; Kono T; Kobayashi H; Ajioka Y; Sugihara K; Ishihara S;
    J Gastroenterol Hepatol; 2024 May; 39(5):893-901. PubMed ID: 38273469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy.
    Okada S; Yamazaki S; Kaiga T; Funada T; Kochi M; Takayama T
    World J Surg Oncol; 2017 Aug; 15(1):162. PubMed ID: 28836976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colitis-Associated Colorectal Cancer Survival is Comparable to Sporadic Cases after Surgery: a Matched-Pair Analysis.
    Raje P; Sonal S; Qwaider YZ; Sell NM; Stafford CE; Boudreau C; Schneider D; Ike A; Kunitake H; Berger DL; Ricciardi R; Bordeianou LG; Cauley CE; Lee GC; Goldstone RN
    J Gastrointest Surg; 2023 Jul; 27(7):1423-1428. PubMed ID: 37165158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer in Crohn's colitis is associated with advanced tumor invasion and a poorer survival compared with ulcerative colitis: a retrospective dual-center study.
    Vetter LE; Merkel S; Bénard A; Krautz C; Brunner M; Mittelstädt A; Schlegel N; Wiegering A; Germer CT; Weber K; Grützmann R; Weber GF
    Int J Colorectal Dis; 2021 Jan; 36(1):141-150. PubMed ID: 32918621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival.
    Björner K; Chen WN; Gannavarapu VR; Axling F; Gulyas M; Halim MA; Webb DL; Hellström PM
    Ups J Med Sci; 2023; 28():. PubMed ID: 38187473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis.
    Han YD; Al Bandar MH; Dulskas A; Cho MS; Hur H; Min BS; Lee KY; Kim NK
    BMC Surg; 2017 Mar; 17(1):28. PubMed ID: 28327112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer.
    Meier C; La Rocca G; Nawrot V; Fißlthaler B; Overby SJ; Hourfar K; Plotz G; Seidl C; Ziegler P; Wild P; Zeuzem S; Brieger J; Jäger E; Battmann A; Brieger A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer.
    Schardey J; Lu C; Neumann J; Wirth U; Li Q; Jiang T; Zimmermann P; Andrassy J; Bazhin AV; Werner J; Kühn F
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's Disease-Associated Anorectal Cancer Has a Poor Prognosis With High Local Recurrence: A Subanalysis of the Nationwide Japanese Study.
    Ogino T; Mizushima T; Fujii M; Sekido Y; Eguchi H; Nezu R; Ikeuchi H; Motoi U; Futami K; Okamoto K; Nagahara H; Watanabe K; Okabayashi K; Yamada K; Ohge H; Tanaka S; Mizuuchi Y; Ohkita Y; Sato Y; Ueno H; Kono T; Itabashi M; Kimura H; Hida K; Kinugasa Y; Takahashi K; Koyama F; Hanai T; Maeda K; Noake T; Shimada Y; Yamamoto T; Arakaki J; Mastuda K; Okuda J; Sunami E; Akagi Y; Kastumata K; Uehara K; Yamada T; Sasaki S; Ishihara S; Ajioka Y; Sugihara K;
    Am J Gastroenterol; 2023 Sep; 118(9):1626-1637. PubMed ID: 36988310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer.
    Swierczynski M; Kasprzak Z; Makaro A; Salaga M
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling.
    Fujita M; Matsubara N; Matsuda I; Maejima K; Oosawa A; Yamano T; Fujimoto A; Furuta M; Nakano K; Oku-Sasaki A; Tanaka H; Shiraishi Y; Mateos RN; Nakai K; Miyano S; Tomita N; Hirota S; Ikeuchi H; Nakagawa H
    Oncotarget; 2018 Jan; 9(1):969-981. PubMed ID: 29416670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms in colitis-associated colorectal cancer.
    Zhou RW; Harpaz N; Itzkowitz SH; Parsons RE
    Oncogenesis; 2023 Oct; 12(1):48. PubMed ID: 37884500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma is associated with a lower incidence of metastatic colorectal cancer in a US patient cohort.
    Beckstead J; Mehrotra K; Wilson K; Fingleton B
    Front Oncol; 2023; 13():1253660. PubMed ID: 37860183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding insult to injury: immunotherapy-induced colitis in metastatic colorectal cancer.
    Wells K
    Proc (Bayl Univ Med Cent); 2024; 37(4):623-624. PubMed ID: 38910825
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
    Goodman KA; Ou FS; Hall NC; Bekaii-Saab T; Fruth B; Twohy E; Meyers MO; Boffa DJ; Mitchell K; Frankel WL; Niedzwiecki D; Noonan A; Janjigian YY; Thurmes PJ; Venook AP; Meyerhardt JA; O'Reilly EM; Ilson DH
    J Clin Oncol; 2021 Sep; 39(25):2803-2815. PubMed ID: 34077237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer.
    Sampaio Moura N; Schledwitz A; Alizadeh M; Patil SA; Raufman JP
    Front Oncol; 2023; 13():1325095. PubMed ID: 38288108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer.
    Feng Y; Yuan Q; Newsome RC; Robinson T; Bowman RL; Zuniga AN; Hall KN; Bernsten CM; Shabashvili DE; Krajcik KI; Gunaratne C; Zaroogian ZJ; Venugopal K; Casellas Roman HL; Levine RL; Chatila WK; Yaeger R; Riva A; Jobin C; Kopinke D; Avram D; Guryanova OA
    J Exp Med; 2023 Nov; 220(11):. PubMed ID: 37615936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma-Recent Findings and Review.
    Borowczak J; Szczerbowski K; Maniewski M; Kowalewski A; Janiczek-Polewska M; Szylberg A; Marszałek A; Szylberg Ł
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884974
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.